Hca Holdings Inc: (NYSE: HCA)

$37.24

-0.42 (-1.12%)

Volume 3,294,597

May 22 02:21 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		37.21 - 38.50
	
		52wk Low - High
		23.91 - 41.83
	
		Previous Close
		37.66
	
		Avg. Volume
		3,839,959
	
		Industry
		MED-HOSPITALS
	
		Market Cap
		16.76 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.41
	
		PE (Forward)
		12.08
	
		Current Year Est.
		3.12
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		94 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/6/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            12.08
                        
                            PEG Ratio
                            1.03
                        
                            Current Year Est.
                            3.12
                        
                            Current Quarter Estimate
                            0.79
                        
                            Most Accurate Estimate
                            0.79
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-05-2013
                        
                            EPS Last Year
                            3.32
                        
                            Expected Earnings Growth
                            11.75%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
HCA Inc. is a non-governmental hospital in the U.S. providing health care and related services. The Company operates a network of acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. The Company also owns and manages freestanding surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, rehabilitation and physical therapy centers, and various other facilities. HCA Inc. is headquartered in Nashville, Tennessee.   
Full HCA Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
HCA Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.79	0.72	3.12	3.77
Number of Estimates	14	13	14	14
Low Estimate	0.70	0.64	3.00	3.27
High Estimate	0.90	0.78	3.41	NA
Year Ago EPS	0.85	0.77	3.71	3.12
EPS Growth	-7.48%	-6.89%	-15.98%	20.85%

More HCA Estimates

Average Earnings Estimates for HCA

EPS Growth for HCA

Industry Analysis

Name	Symbol	Previous Close
HCA HOLDINGS	HCA	37.66
VCA ANTECH INC	WOOF	24.79
ACADIA HEALTHCR	ACHC	32.07
COMMNTY HLTH SY	CYH	43.23
LIFEPOINT HOSP	LPNT	47.29
MEDNAX INC	MD	93.40
TENET HEALTH	THC	45.11
UNIVL HLTH SVCS	UHS	66.41
VANGUARD HEALTH	VHS	11.95
HEALTH MGT ASSC	HMA	10.79

Sector:Medical>> Industry:MED-HOSPITALS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Sneak Peek of 1Q Earnings of HCA

Apr 17, 2013

Tenet Prices Senior Notes

Jan 25, 2013

The Zacks Analyst Blog Highlights: CIT Group, HCA Holdings, SLM Corp., iShares iBoxx $ High Yield Corporate Bd and SPDR Barclays High Yield Bond

Jan 22, 2013

Is the Party Over for Junk Bonds?

Jan 21, 2013

AmSurg Stays at Neutral

Dec 18, 2012

Tenet Misses, Improves Y/Y

Nov 07, 2012

Amsurg Meets Ests, Outlook Up

Oct 26, 2012

Tenet Downgraded to Neutral

Oct 22, 2012

More HCA Zacks Commentary

Financials

EPS TTM	3.32
Sales	33,013
Net Income	1,409
Price/Earnings	11.34
Price/Book	NA
Price/Cash Flow	4.84
Price/Sales	0.51

More HCA Financials

News

Critical Alerts For Sanofi, Salesforce.com, AFLAC, HCA Holdings, and Silver Wheaton Released By InvestorsObserver - Pr Newswire

May 22, 2013

HCA Announces 41st Annual Frist Humanitarian Awards Recipients - Businesswire

May 20, 2013

Potential HCA (HCA) Trade Has $37.25 Breakeven - Freshbrewedmedia

May 16, 2013

HCA, THC, HMA, and UHS Under StockCall's Microscope - Accesswire-Tnw

May 15, 2013

UPDATE: BMO Capital Markets Raises PT on HCA Holdings Following In-Line 1Q Results - Benzinga

May 13, 2013

This News Is Bound to Give Obamacare a Big Boost - TheMotleyFool

May 12, 2013

HCA (HCA) Trading Near $39.39 Support Level - Freshbrewedmedia

May 10, 2013

HCA Holdings Inc hires Ann Huntress Lamont to board - M2

May 10, 2013

See All News Stories on HCA

Broker Recommendations

Current ABR	1.37
ABR (Last Week)	1.37
# of recs in ABR	15
Average Target Price	42.76
Industry Rank by ABR	94 out of 265
Rank in Industry	3 out of 10

More HCA Broker Recommendations

Day Low - High	37.21 - 38.50
52wk Low - High	23.91 - 41.83
Previous Close	37.66
Avg. Volume	3,839,959
Industry	MED-HOSPITALS
Market Cap	16.76 B
Div - Yield	0.00 - 0.00
Beta	0.41
PE (Forward)	12.08
Current Year Est.	3.12
Quarterly Earnings ESP	0.00%

PE (Forward)	12.08
PEG Ratio	1.03
Current Year Est.	3.12
Current Quarter Estimate	0.79
Most Accurate Estimate	0.79
Earnings ESP	0.00%
Next Earnings Report Date	08-05-2013
EPS Last Year	3.32
Expected Earnings Growth	11.75%

Username: Password:

Remember me [?]

Hca Holdings Inc: (NYSE: HCA)

$37.24

-0.42 (-1.12%)

Volume 3,294,597

May 22 02:21 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description